CD4 and colitis: They have been shown to impact key target cell populations for SIV acquisition and disease progression in the colon, such as Th17+ CD4+ T cells [20], as well as inducing colitis, which has been shown to have a significant impact on acquisition and disease progression in SIV/SHIV models [23, 27, 28].